FSH is an ␣/␤ heterodimeric glycoprotein, the formation of which is regulated primarily by expression of its ␤-subunit. Recent studies on transcriptional regulation of the ovine FSH ␤-subunit gene (oFSH␤) have defined two functional activating protein-1 (AP-1) enhancers in the proximal promoter (located at Ϫ120 and Ϫ83 bp) that are probably physiologically important for FSH␤ expression. As
in the proximal promoter of oFSH␤. Gel shift assays demonstrated the ability of GnRHR in HeLa cells to increase AP-1 binding activity. Responses in the HeLa cell system were dependent on GnRH (ED 50 ϭ 0.5 nM) and GnRHR, which was identified by photoaffinity labeling. In addition, GnRHR-expressing HeLa cells exhibited a normal GnRHdependent mobilization of intracellular calcium. Finally, as protein kinase C (PKC) is a known target of GnRH action in gonadotropes, the role of PKC in transcriptional regulation of oFSH␤ and ␣-subunit genes by GnRH in HeLa cells was investigated. Although 12-O-tetradecanoyl 13-acetate induction of ␣-Luc and Ϫ215oFSH␤-Luc could be completely blocked in a dose-dependent manner by the specific PKC inhibitor bisindolylmaleimide I, only 57-65% of the GnRHmediated stimulation of these promoters was blocked, demonstrating the involvement of PKC as well as other signaling systems in GnRH induction. These data define a molecular action of GnRH on oFSH␤ gene transcription that involves two proximal AP-1 enhancer elements and PKC activation. Furthermore, these studies establish the usefulness of HeLa and COS-7 cells to investigate specific aspects of GnRH action on gonadotropin subunit gene expression, as similar signaling pathways and transcription factors that are activated by GnRH in gonadotropes (such as PKC, mitogen-activated protein kinase, Ca 2ϩ , and AP-1) exist in these cells. (Endocrinology 139: 4455-4465, 1998) F SH IS AN ␣/␤ heterodimeric glycoprotein hormone necessary for folliculogenesis and the female reproductive cycle. It is produced, along with LH, in gonadotropes of the anterior pituitary. The ␣-subunit in FSH is also common to LH, but the biological activity of each hormone is defined by its unique ␤-subunit (1) . As expression of the ␤-subunit for FSH is the primary rate-limiting step in overall FSH production, those factors controlling FSH␤ synthesis are the key regulators of gonadal and reproductive function.
One primary regulator of FSH␤ expression in vivo is GnRH. This decapeptide hormone is released from the hypothalamus and binds a specific G protein-coupled receptor (GnRHR) on plasma membranes of gonadotropes to activate intracellular signals that lead to gonadotropin secretion and increased transcription of all gonadotropin subunits (1) (2) (3) . Evidence is now emerging that GnRH induces and/or activates components of the AP-1 transcriptional complex, which usually consists of Jun/Jun homodimers or Jun/Fos heterodimers that bind target genes to increase their expression. It has been shown that GnRH administration to cultured rat pituitary or immortal ␣T3-1 gonadotrope cells causes a rapid increase in the messenger RNAs (mRNAs) for the protooncogenes c-jun, junB, and c-fos (4) . Additionally, pulsatile administration of GnRH to ovariectomized hypogonadotropic (GnRH-deficient) lambs was shown to increase pituitary mRNAs for c-jun and c-fos (5) . This same study demonstrated that pituitary levels of c-jun mRNA increased 2-to 3-fold just before the preovulatory LH surge, strongly suggesting that dynamic changes in activating protein-1 (AP-1) transcriptional complexes were occurring in gonadotropes throughout the reproductive cycle. Finally, it has been shown that GnRH administration to perifused rat pituitary cells activates protein kinase C (PKC), and PKC is a known activator of c-jun (6, 7) . These data, taken together, imply an important role for AP-1 transcriptional complexes in gonadotropes and, further, suggest the possibility that GnRH action on gonadotropin subunit gene expression may include mechanisms involving AP-1.
Recent studies with the ovine FSH␤ gene (oFSH␤) uncovered two functionally linked AP-1 sites in the proximal promoter, lending strength to a hypothesis that FSH␤ gene transcription in vivo is regulated at least in part through Jun and Fos family members (8) . Additionally, these studies provided the first evidence that the proteins for Jun and Fos family members are directly expressed in a majority of gonadotropes in vivo, demonstrating that AP-1 is present to potentially act on the oFSH␤ gene. Working on the hypothesis that GnRH is an important regulator of FSH␤, and that AP-1 may be a component of GnRH action on FSH␤ gene transcription, we engineered an in vitro cell assay system to analyze regulatory elements involved in GnRH action on the FSH␤ gene. In this report we use such a system to demonstrate that transcriptional activation of the oFSH␤ gene by GnRH in HeLa cells involves each of the previously characterized AP-1 sites in the oFSH␤ gene and, further, show that this stimulation partially involves PKC activation. HeLa cells were used as a model system because there are no FSH␤-producing cell lines available and because all transformed pituitary cell lines known to date poorly express oFSH␤ promoter/luciferase constructs. These data are the first to characterize a mechanism of action of GnRH at the level of FSH␤ promoter sequence and provide a direct physiological role for GnRH-induced AP-1 transcriptional complexes in gonadotropes.
Materials and Methods

Plasmid constructs
Generation of the deletion and site-directed mutation constructs containing 5Ј-regions of the ovine FSH␤ promoter fused to the luciferase gene has been previously described (8) . Luciferase expression plasmids containing either the Ϫ846/ϩ44 region of the human ␣-subunit promoter or the Rous sarcoma virus (RSV) promoter (␣-Luc and RSV-Luc, respectively) (9) were provided by Dr. J. Larry Jameson (Department of Medicine, Northwestern University, Chicago, IL). The cytomegalovirus (CMV) mouse GnRHR expression plasmid (10) was a gift from Dr. Stuart C. Sealfon (Mt. Sinai School of Medicine, New York, NY). The RSV-␤-galactosidase expression construct (pRSV␤gal), an internal control for these studies, has been described previously (8) .
Cell culture and transient transfection
HeLa and COS-7 cells were obtained from the American Type Culture Collection (Manassas, VA). ␣T3-1 cells were provided by Dr. Pamela L. Mellon (University of California-San Diego, La Jolla, CA). All transformed cells in this study were grown at 37 C in DMEM (Life Technologies, Grand Island, NY) containing 10% FBS (HyClone Laboratories, Inc., Logan, UT) under 95% air-5% CO 2 . Cells used for transfection were grown in 150-cm 2 flasks until they were confluent and then were replated in six-multiwell plates (diameter, 35 mm/well) at a concentration of 300,000 cells/well the day before transfection. Unless otherwise indicated, HeLa cells were transiently transfected in triplicate with 8 g reporter construct, 1 g GnRHR, and 10 g pRSV␤gal (total volume, 0.5 ml) using the calcium phosphate method (11) . COS-7 cells were transfected in the same way as HeLa cells, except that 6 g reporter construct and 4 g pRSV␤gal were used. Eighteen hours after the start of transfection, the precipitates were removed and replaced with low serum medium (0.5% FBS). Six hours later, cells were treated with either 100 nm GnRH (Sigma Chemical Co., St. Louis, MO) or 10 nm 12-O-tetradecanoylphorbol 13-acetate (TPA; Calbiochem-Novabiochem International, La Jolla, CA). For transfection studies involving the PKC inhibitor bisindolylmaleimide I (BIM; also known as GF 109203X; CalbiochemNovabiochem International), HeLa cells were pretreated with the indicated concentration of BIM 15 min before the addition of GnRH or TPA. Cells were harvested for determination of luciferase and ␤-galactosidase activities 12 h after GnRH or TPA treatment. Luciferase and ␤-galactosidase activity assays from transient transfections were performed as previously described (8) .
Normalization and statistical analysis of the transient transfection data
Activity in the internal control ␤-galactosidase expression construct, pRSV␤gal, was used to normalize the transfection efficiency in HeLa or COS-7 cell culture studies. The transfected gene for ␤-galactosidase typically showed 5-to 10-fold higher activity than the endogenous ␤-galactosidase gene in all transfections. Variation in transfection efficiency was normalized by dividing the ␤-galactosidase values directly into the luciferase values from control and GnRH-or TPA-treated cultures. Expression of the pRSV␤gal construct under GnRH treatment was enhanced 1.5-to 1.8-fold in these experiments. Because the expressions of RSV-Luc, Ϫ84oFSH␤-Luc, and Ϫ120/Ϫ83 mut FSH␤-Luc were increased to the same degree as that of pRSV␤gal, this slight enhancement was judged to be a nonspecific effect caused by GnRH. Thus, although the negative control RSV-Luc and deletion/mutation oFSH␤-Luc constructs listed above were normalized to about 1.0 (no stimulation), a typical 5.0-to 6.0-fold increase in Ϫ215oFSH␤-Luc expression was normalized to 3.2-to 3.8-fold.
To combine data from independent experiments, the basal expression for each construct in each experiment was averaged and then assigned a relative value of 1 (see figures). Induction ratios (fold induction) were obtained by dividing the average value for the GnRH-induced or TPAinduced reporter by the average basal expression of the same reporter. Differences between means obtained for basal expression, stimulated GnRH or TPA expression, and induction ratios of all luciferase expression constructs were determined using ANOVA followed by Tukey's multiple range test for individual comparisons (12) .
Measuring intracellular calcium ([Ca 2ϩ ]i)
HeLa cells were transiently transfected as described above, using 1 g GnRHR and 18 g Bluescript or Bluescript alone (19 g ). Eighteen hours after transfection, HeLa cells as well as ␣T3-1 cells were plated into four-well Nunc chamber slides (Fisher Scientific International, Inc., Pittsburgh, PA; catalog no. 1256517) and cultured 24 h before treatment with 100 nm GnRH. According to protocols provided by Molecular Probes, Inc., cells were loaded with 4 m indo-1/AM, washed in HBSS (1 mm Ca 2ϩ ), and mounted on an ACAS 570 Interactive Laser Cytometer (Meridian Instruments, Inc., Ann Arbor, MI). Two-dimensional spatial fluorescent 10-sec image scans were collected before and after GnRH treatment. Intracellular calcium concentrations ([Ca 2ϩ ]i) were determined using quantitative ratiometric fluorescence analysis. The total number of lines in each graph corresponds to the total number of cells in the field of analysis. Each line in the graph represents the change in [Ca 2ϩ ]i within a single cell.
Photoaffinity labeling of GnRHR
HeLa cells were transiently transfected as described above using 1 g GnRHR and 18 g Bluescript or Bluescript alone (19 g ). Transfected HeLa and ␣T3-1 cells used for photoaffinity labeling studies were harvested and stored at Ϫ80 C before analysis. HeLa cells (3 ϫ 10 6 ) or ␣T3-1 cells (9 ϫ 10 6 ; equal cell pellet sizes) were incubated with 100,000 cpm [ 125 I]GnRH-N-hydroxysuccinimidyl-4-azido-benzoate (13) at 4 C for 4 h and then exposed to a mercury lamp for 5 min to covalently link the radiolabeled ligand to the GnRHR. Radiolabeled GnRHR was fractionated using 10% SDS-PAGE. Gels were fixed, dried, and visualized by a PhosphorImager (model 445 SI, Molecular Dynamics, Inc., Sunnyvale, CA).
Electrophoretic mobility shift analysis
To analyze induction of nuclear proteins by GnRH, HeLa cells were stably transfected with the GnRHR expression plasmid. Twenty micro-grams of BglII-linearized CMV-GnRHR were transfected as described above, and HeLa cells expressing CMV-GnRHR were selected using G418 (Mediatech, Herndon, VA). Individual HeLa cell colonies were isolated, expanded, and analyzed for GnRHR expression by assaying for GnRH induction of transiently transfected Ϫ215oFSH␤-Luc.
Micropreparations of nuclear protein extracts from stably transfected HeLa (HeLa-Rec) or ␣T3-1 cells were prepared as described by Andrews and Faller (14) , using 1 ϫ 10 6 HeLa-Rec or 3 ϫ 10 6 ␣T3-1 cells. Before harvesting, cells were incubated for 12 h in low serum medium and then were treated with or without 100 nm GnRH for 1 h. Binding reactions with HeLa-Rec or ␣T3-1 nuclear extract were performed by mixing 8 g nuclear protein with binding buffer [final concentrations, 1 mm MgCl 2 , 2 mm EDTA, 2 mm dithiothreitol, 25 mm NaCl, 10 mm Tris-Cl (pH 7.5), and 4% glycerol], 0.75 g poly(dI-dC) (Boehringer Mannheim, Indianapolis, IN), and 0.4 ng (13,000 -14,000 cpm) end-labeled AP-1 consensus (Promega Corp., Madison, WI) at room temperature in 20-l reaction volumes. All binding reactions (including those with competitor oligonucleotides or antibodies) were carried out simultaneously. For supershift assays, 0.15 g anti-Fos rabbit polyclonal antibody (provided by Dr. M. J. Iadarola, NIH, Bethesda, MD) (15), 0.5 g anti-JunD rabbit polyclonal antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) or 0.5 g nonspecific rabbit IgG (Sigma) were preincubated in the binding reactions for 15 min at room temperature before the addition of radiolabeled probe. The anti-Fos antibody is directed to residues 128 -152 of human c-Fos and recognizes all of the Fos family members (c-Fos, FosB, Fra-1, and Fra-2). The affinity-purified rabbit anti-JunD polyclonal antibody was directed against residues 329 -341 of mouse JunD and was specific for JunD only (confirmed by Santa Cruz Biotechnology, Inc. using Western blot analysis). For competition studies, unlabeled AP-1 or SP-1 competitor oligonucleotides (Promega Corp.) were preincubated in binding reactions at a 75-fold molar excess for 15 min before the addition of radiolabeled probe. After the addition of probe, all binding reactions were incubated for an additional 25 min at room temperature before being loaded onto 5.6% nondenaturing polyacrylamide gels (1.5 mm), which were run at 200 V for 1.5 h at 4 C in 0.5 ϫ TBE (0.089 m Tris; 0.089 m borate; 0.002 m EDTA). Gels were fixed, dried, and visualized by a PhosphorImager (model 445 SI, Molecular Dynamics, Inc.).
Results
Using HeLa cells to study transcriptional regulation of oFSH␤ by GnRH
HeLa cells were chosen to study the effects of GnRH on oFSH␤-Luc expression because this cell line is well characterized and readily expresses oFSH␤-Luc constructs, and none of the pituitary or GnRHR-expressing cell lines tested, such as ␣T3-1, GH 3 , RC-4B/C, and GT-1 cells, efficiently expresses oFSH␤ promoter/luciferase expression constructs. To investigate the ability of GnRHR to activate oFSH␤ gene transcription, increasing amounts of mouse GnRHR expression plasmid were cotransfected along with a luciferase expression construct containing the Ϫ215/ϩ759 region of the oFSH␤ gene (Ϫ215oFSH␤-Luc) into HeLa cells that were subsequently treated with 100 nm GnRH for 12 h. As shown in Fig. 1A , the promoter activity of Ϫ215oFSH␤-Luc increased with increasing amounts of cotransfected GnRHR. A maximal response of 3.8 Ϯ 0.8-fold was obtained with 1 g GnRHR and remained constant with up to 4 g GnRHR (3.5 Ϯ 0.5-fold induction). Similar induction of Ϫ215oFSH␤-Luc by GnRH was observed as early as 6 h and as late as 18 h (data not shown). Stimulation by GnRH was dependent upon cotransfection of GnRHR. The ED 50 of GnRH action was determined from a dose-response study using 1 g GnRHR. As Fig. 1B shows, increasing amounts of GnRH resulted in a dose-dependent increase in Ϫ215oFSH␤-Luc promoter activity with an ED 50 of 0.5 nm. It is notable that this response is in the range of normal GnRHR action in gonadotropes (4, 16) .
GnRHR action in gonadotropes results in a rapid and transient mobilization of intracellular calcium. To determine whether GnRHR-expressing HeLa cells would mobilize calcium as normally observed in gonadotropes, calcium mobilization studies were performed. As shown in Fig. 1C , addition of 100 nm GnRH to HeLa cells transiently expressing GnRHR resulted in mobilization of intracellular calcium similar to that observed in ␣T3-1 cells. More than three independent experiments showed similar results with calcium responses in ␣T3-1 and GnRH-responsive HeLa cells typically ranging from 0.2-3.5 m after GnRH treatment. The level of calcium mobilized in GnRH-responsive HeLa cells is similar to that reported for ovine pituitary gonadotropes (17) . As only a small population of HeLa cells actually became transfected with GnRHR using the CaPO 4 method (15-30%), only a limited number of cells were expected to be responsive to GnRH. HeLa cells transfected only with control plasmid DNA (Bluescript) lacked the ability to mobilize intracellular calcium in response to GnRH. Ionomycin, a calcium ionophore that permits calcium to flow freely into cells, was used as a positive control in each study to confirm the integrity of the calcium detection system (data not shown).
To explore the physical nature of GnRHR expressed in HeLa cells, GnRHR from transiently transfected HeLa cells were radiolabeled by photoaffinity labeling methods using [ (Fig. 1D, lane 1) . The photoaffinity labeling of [ 125 I]azidobenzoyl-GnRH-A to GnRHR in ␣T3-1 cells was specific, as the addition of 100 nm GnRH-A (unlabeled competitor) to the binding reaction prevented formation of the radiolabeled band (Fig. 1D, lane 2) . HeLa cells transiently transfected with GnRHR contained a radiolabeled band with an apparent molecular mass of 63 kDa (Fig. 1D, lane  4) . This band was specific, as 100 nm GnRH-A prevented the photoaffinity labeling with [ 125 I]azidobenzoyl-GnRH-A (Fig.  1D, lane 5) . Without the cotransfection of GnRHR, no radiolabeled bands were observed (Fig. 1D, lane 3) . To address whether the higher molecular mass form of GnRHR in HeLa cells was due to differences in glycosylation, we used the recombinant glycosidase peptide-N-glycosidase F (Oxford GlycoSciences, Inc., Bedford, MA) to cleave all carbohydrates from the GnRHR and found that deglycosylated GnRHR from either transfected HeLa or ␣T3-1 cells exhibited a single major band at 28 kDa (data not shown). It should be noted that other studies have shown a similar apparent molecular mass of 57-65 kDa for mouse GnRHR expressed in COS-1 cells and that this receptor binds GnRH with wild-type affinity (18) .
GnRH induces Ϫ4741oFSH␤-Luc and human ␣-Luc in transformed cell types
The ␣-subunit gene is known to be GnRH responsive through several characterized promoter elements (reviewed in Refs. 19 and 20) . To determine whether GnRH-responsive HeLa cells would support stimulation of the human ␣-sub- . DNA concentrations in precipitates were kept constant using Bluescript DNA. Upon removal of the DNA precipitates, cells were cultured in low serum (0.5% FBS) for 9 h followed by administration of 100 nM GnRH for the final 12 h of incubation. B, GnRH dose response with the Ϫ215oFSH␤-Luc. HeLa cells transiently transfected with Ϫ215oFSH␤-Luc and GnRHR were cultured as described above and treated with 0.01, 0.1, 1, 10, 100, or 1000 nM GnRH for 12 h before harvesting. In each case, basal expression of Ϫ215oFSH␤-Luc was assigned (normalized to) a relative value of 1. Values represent the mean Ϯ SEM from unit gene in addition to a 4.7-kb oFSH␤ promoter construct, luciferase expression constructs containing either the Ϫ846/ ϩ44 region of the human ␣-subunit gene (␣-Luc) or the Ϫ4741/ϩ759 region of the oFSH␤ gene (Ϫ4741oFSH␤-Luc) were assayed for GnRH stimulation as described above. As a negative control, a luciferase expression construct containing the RSV promoter (RSV-Luc) was also assayed. As shown in Fig. 2 , both Ϫ4741oFSH␤-Luc and ␣-Luc were stimulated (3.1 Ϯ 0.3-and 7.7 Ϯ 1.9-fold, respectively) by 100 nm GnRH, whereas RSV-Luc expression was not changed. Similar results with these constructs were observed in COS-7 cells (Fig.  2) , indicating that this regulation is not restricted to HeLa cells. It should be noted that the level of stimulation caused by GnRH in these gonadotropin subunit promoters in HeLa and COS-7 cells are within the ranges observed by others for these genes both in vivo and in vitro (2, 3, 21, 22) . Several other cell lines tested for GnRH stimulation (JAR, T47-D, and NIH 3T3), however, did not result in significant levels of Ϫ4741oFSH␤-Luc and ␣-Luc stimulation (data not shown), suggesting that either factors required for GnRH induction are absent from these cell types or that GnRHR is not efficiently expressed.
Localization of the GnRH-responsive region in the oFSH␤ gene
A series of progressive 5Ј-deletion constructs of the oFSH␤ gene fused to the luciferase gene were assayed in the HeLa cell system to determine the promoter regions associated with GnRH induction. As shown in Fig. 3 , constructs containing deletions from Ϫ4741 to Ϫ215 bp were stimulated between 2.8-to 3.2-fold by 100 nm GnRH. An additional deletion to Ϫ84 bp resulted in a complete loss of GnRH responsiveness, demonstrating that sequences between Ϫ215 and Ϫ84 bp are involved in the GnRH-mediated induction of oFSH␤-Luc. Basal expression of all deletion constructs was statistically equivalent (P Ͼ 0.05) and did not vary by more than 15,000 -30,000 relative light units/100 l (1/10th of the total sample) between individual experiments.
The Ϫ120 and Ϫ83 AP-1-binding sites each function to enhance oFSH␤-Luc transcription by GnRH
The deletional data described above along with the knowledge that GnRH action leads to the induction of AP-1 suggested that the GnRH-mediated induction of oFSH␤-Luc involved the AP-1 sites located at Ϫ120 and Ϫ83 bp. To determine whether the Ϫ120 and Ϫ83 sites played any role in the induction of oFSH␤ by GnRH, each site was mutated in Ϫ215oFSH␤-Luc (individually or collectively) and analyzed under GnRH stimulatory conditions as described above. As shown in Fig. 4 , mutations in either site significantly reduced (P Ͻ 0.05) the level of GnRH activation of Ϫ215oFSH␤-Luc from 3.2-fold to about 2-fold (50% reduction). Luciferase expression of a construct containing mutations at both sites (Ϫ83/-120 mutFSH␤-Luc) was not en- hanced by GnRH, demonstrating that both sites are essential for GnRH induction. To determine whether any up-stream regions (Ͼ215 bp) in the oFSH␤ gene possessed functional elements that might be contributing to the GnRH induction, the Ϫ120 and Ϫ83 sites were mutated in Ϫ4741oFSH␤-Luc by site-directed mutagenesis and assayed for GnRH responsiveness as described. The results of these studies paralleled those observed with the Ϫ215oFSH␤-Luc mutation constructs, indicating that the two AP-1 sites in the oFSH␤ gene are the only GnRH-responsive elements that can be detected in HeLa cells (data not shown). Basal level expression of all constructs containing wild-type or mutated oFSH␤ sequences did not vary significantly between individual experiments.
GnRH increases AP-1-binding activity in ␣T3-1 and GnRHR-expressing HeLa cells
To determine whether GnRH increased AP-1-associated DNA binding in GnRHR-expressing HeLa cells, a stable HeLa cell line expressing GnRHR (HeLa-Rec) was produced, and nuclear extracts from control and GnRH-treated HeLaRec cultures were prepared for gel shift analyses employing a radiolabeled AP-1 consensus ([ 32 P]conAP-1 before fractionation on a polyacrylamide gel. As shown in Fig. 5 (lanes 6, 7, 13, and 14) , the anti-Fos and anti-JunD antibodies were each able to supershift the DNA-protein complexes formed under GnRHtreated ␣T3-1 and HeLa-Rec cells, whereas nonspecific rabbit IgG could not (lanes 8 and 15) . The Fos antibody, in addition to supershifting, showed the ability to prevent the formation of DNA-protein complexes (Fig. 5, lanes 7 and 14) . Additional supershift experiments showed that the DNAprotein complexes formed from control extracts also contained JunD and Fos proteins (data not shown).
Transcriptional activation of oFSH␤-Luc and ␣-Luc is mediated in part through PKC
The role of PKC in GnRH-induced activation of Ϫ215oFSH␤-Luc and ␣-Luc in HeLa cells was investigated using a highly specific inhibitor of PKC activation, BIM (also known as GF 109203X). As a positive control of PKC inhibition, varying concentrations of BIM (from 1 nm to 2 m) were administered to HeLa cells transfected with Ϫ215oFSH␤-Luc or ␣-Luc before the addition of 10 nm TPA for 12 h. As shown in Fig. 6, A and B , increasing concentrations of BIM completely blocked a TPA-mediated PKC response (in a dose-dependent fashion) for both the oFSH␤ and ␣-subunit genes. Under similar experimental conditions, GnRH induction of either ␣-Luc or Ϫ215oFSH␤-Luc was reduced by 57% and 65%, respectively, by BIM (Fig. 6, C and  D) , suggesting that GnRH is targeting PKC in addition to other signaling pathways to stimulate gonadotropin subunit gene transcription in HeLa cells. Similar results were obtained when another highly specific and structurally different PKC inhibitor, chelerythrine chloride, was tested (data not shown). 
Discussion
Recent studies have identified two functionally linked AP-1-like enhancer elements in the proximal promoter of the ovine FSH␤ gene (8) . These sites, located at Ϫ120 and Ϫ83 bp, bind c-Jun and Fos proteins in vitro as well as mediate a phorbol ester (TPA) response in cell culture. Because 75-85% of ovine gonadotropes possess Jun/Fos family members in vivo, the data strongly suggest that these AP-1 sites are important for expression of the oFSH ␤-subunit (8). One regulator of FSH␤ expression that may mediate its effects through AP-1 is GnRH. Not only has it been shown that GnRH can increase the rate of transcription of the FSH␤ gene in rat pituitaries in vivo, but GnRH also induces AP-1 family members in both cultured rat pituitary cells and ovine pituitaries in vivo (4, 5) . These data, taken together, suggest that the regulation of FSH␤ gene transcription by GnRH is likely to involve mechanisms including AP-1.
To determine whether GnRH regulation of oFSH␤ gene transcription involves the two oFSH␤ AP-1 sites, a GnRHresponsive HeLa cell system was established through transient expression of mouse GnRHR along with oFSH␤ promoter/luciferase constructs. These cells responded to GnRH by inducing oFSH␤-Luc expression 2.8-to 3.8-fold when the constructs contained both AP-1 sites. Site-directed mutation of either the Ϫ120 or Ϫ83 sites resulted in a significant reduction of GnRH stimulation (50%), and a double mutation abolished all GnRH responsiveness. These results demonstrated that each site independently promotes GnRHstimulated transcription.
Although the data presented here show that both sites function independently under GnRH, previous data demonstrated that each site is required for c-Jun/c-Fos or TPA induction (8) . It is unclear why the mechanism of GnRH regulation differs from that of AP-1 regulation, but several theories are suggested. First, it is known that GnRH induces certain Jun/Fos family members, so it may be that specific combinations of Jun and Fos induced by GnRH function at each site independently (4) . Binding studies show, for instance, that each site has specific capacities to bind different AP-1 family members (our unpublished data). Further, certain combinations of Jun and Fos family members possess distinct and separate affinities for an AP-1 consensus, and these combinations possess unique biological activities different from those of c-Jun/c-Fos (23, 24) . A second hypothesis to explain the differences between AP-1 and GnRH regulation may be found in the ability of GnRH to induce non-AP-1 proteins that cooperate with Jun or Fos to bind and transactivate oFSH␤ through each site. In support of this, data show that the Ϫ120 and Ϫ83 sites bind proteins other than AP-1 (8) . It may be that these proteins, in conjunction with Jun or Fos, bind to and activate transcription through each site. Finally, it is possible that additional GnRH-responsive elements/regions exist between sequences Ϫ215 and ϩ759, allowing each site to cooperate with a yet unknown factor. Theoretical support for this comes from the concept that a composite region consisting of separate and distinct elements participates in mediating normal GnRH regulation of the ␣-subunit promoter (reviewed in Refs. 19 and 20) . Thus, it is possible that other elements in the oFSH␤ gene may also be involved in mediating the observed GnRH regulation. Studies are underway to determine which, if any, of the theories described above are correct.
The Ϫ120 AP-1 site is conserved in the FSH␤ genes of all species analyzed to date (sheep, cow, pig, human, rat, mouse, and rabbit). This suggests a universal involvement of the Ϫ120 site in GnRH induction of most, if not all, mammals. For the Ϫ83 site to be considered part of the normal GnRH response in vivo, one would predict that it should also be a common feature of all FSH␤ genes, but the Ϫ83 site is conserved only among the ovine, bovine, and porcine species. In addition, oligonucleotides coding for the human, rabbit, and rat Ϫ83 sites show no ability to compete for AP-1 proteins (our unpublished results). As the rat FSH␤ gene has been shown to be transcriptionally activated by GnRH, and to similar or higher levels than those reported here, these data suggest that other sites, in addition to the Ϫ120 site, contribute to the GnRH responsiveness in these FSH␤ genes (2, 21) .
Given that the Ϫ120 and Ϫ83 sites appear to be important for GnRH regulation of oFSH␤ gene transcription, a comparison of these elements was made to those identified as being involved in GnRH regulation of other GnRH-responsive genes. Comparison of the Ϫ83 AP-1 site to these elements reveals a striking sequence similarity between the Ϫ83 site and the pituitary glycoprotein hormone basal element (PGBE) located in the mouse ␣-subunit promoter at Ϫ342 bp (Ϫ83: 5Ј-CTTACTAAT-3Ј; PGBE: 5Ј-taCTTAgCTAATta-3Ј; lower case letters in the PGBE represent sequence mismatches to oFSH␤ sequences, and underlined letters highlight regions of high homology) (22) . The PGBE acts as a basal enhancer and is reported to bind members of the LIM homeodomain family of transcription factors, including LH-2 and mLim-3 (22, 25) . These factors are thought to bind to the PGBE and cooperate with other GnRH-responsive elements in the ␣-subunit promoter to promote GnRH induction. Mutating the PGBE severely disrupts GnRH responsiveness as well as LH-2 binding (22, 25) . As gel shift studies with the Ϫ83 AP-1 site using HeLa nuclear extract demonstrate the ability of the Ϫ83 AP-1 site to bind proteins other than AP-1, it may also be that the Ϫ83 site of oFSH␤ binds LIM homeodomain transcription factors. The ability of the Ϫ83 site in the oFSH␤ gene to bind to and be trans-activated by LH-2 or mLim-3 awaits confirmation.
A comparison of the Ϫ120 and Ϫ83 AP-1 sites in oFSH␤ can be made to the tandem cAMP response elements (CREs) located in the human ␣-subunit gene, which appear to play a role in GnRH-regulated ␣-subunit gene transcription (Jameson, J. L., personal communication). Consensus CREs differ by only one nucleotide from consensus AP-1 enhancer elements (CRE: TGACGTCA; AP-1: TGA C / G TCA) and it has been demonstrated that both elements can be regulated by Jun/Fos as well as CRE-binding factors (24) . Because GnRH action in gonadotropes is known to induce AP-1 transcriptional complexes, such regulation by GnRH at the tandem CREs may involve Jun and/or Fos family members. In support of this, studies in our laboratory show that human ␣-Luc is stimulated 5-fold by c-Jun/c-Fos transcriptional complexes in HeLa cells (unpublished data). Therefore, AP-1 may be a common regulatory mechanism used by GnRH to stimulate the ␣-and FSH ␤-subunit genes.
Studies with GnRH-responsive HeLa and COS-7 cells showed that GnRH could stimulate the promoter activities of human ␣-Luc and Ϫ4741oFSH␤-Luc (but not RSV-Luc) to physiologically relevant levels (approximately 7-and 3-fold, respectively). These data suggest that HeLa and COS-7 cells contain the required components necessary for proper GnRH signaling to these gonadotropin subunit genes. This is probably due to the fact that these cell lines possess many of the major signaling pathways and some of the transcription factors known to be important for GnRH regulation of ␣-subunit gene transcription, including PKC, mitogen-activated protein kinase members ERK1 and ERK2, as well as Ets family members (26 -30) . In addition, it is well established that HeLa and COS-7 cells contain PKC-inducible AP-1 transcription complexes, which appear to be important for FSH␤ transcription in gonadotropes. Thus, it is reasonable to conclude that the observed GnRH-induced regulation found in HeLa and COS-7 cells is probably physiologically relevant.
PKC inhibition studies demonstrated the involvement of PKC in GnRH-mediated induction of both human ␣-Luc and Ϫ215oFSH␤-Luc in HeLa cells (57-65% of the GnRH-mediated stimulation of these promoters was blocked by BIM). Because these same studies showed that a TPA-induced PKC response can be completely blocked by BIM, these data indicate that GnRH action in HeLa cells involves PKC as well as additional signaling mechanisms. It is notable that others have observed PKC involvement in GnRH-mediated ␣-Luc expression in ␣T3-1 cells (31). It is not clear what additional signaling mechanisms are involved in this GnRH induction, although it may include mechanisms involving Ca 2ϩ /calmodulin, as an antagonist of calmodulin activity (W-7) completely blocked the GnRH response to oFSH␤-Luc (data not shown).
Given that GnRHR-expressing HeLa cells represent a new cell system to study the effects of GnRH, studies were performed to characterize their physical and functional nature. Cotransfection studies revealed the ability of GnRHR to activate Ϫ215oFSH␤-Luc transcription in both a dose-and receptor-dependent manner, suggesting normal GnRHR function in these cells. Further investigations to determine whether GnRHR was targeting gonadotrope-specific signal-ing pathways in HeLa cells showed that GnRHR was capable of mobilizing intracellular calcium similar to that observed in ␣T3-1 and ovine gonadotrope cells. In addition, gel shift studies demonstrated the ability of GnRHR in HeLa cells to activate/induce components of AP-1 as is normally seen in ␣T3-1 cells, albeit to a lesser extent. These studies, taken together, suggest that GnRHR is not only expressed at physiologically relevant levels in these HeLa cells, but is capable of signaling through pathways that are similar or common to those used by gonadotropes.
Through photoaffinity labeling studies it was determined that mouse GnRHR expressed in HeLa cells was higher in molecular mass compared with endogenous mouse GnRHR expressed in ␣T3-1 cells. Subsequent glycosidase studies, however, revealed that this higher molecular mass was due to differences in glycosylation between these receptors (data not shown). Differences in the glycosylation patterns observed are probably due to the differences between HeLa cells and gonadotropes in their protein secretion and maturation pathways. Nevertheless, additional glycoslyation on GnRHR has been shown to not alter normal GnRH binding and, further, appears to not alter its normal function (18) .
Regulation of gonadotropin subunit expression by GnRH in vivo normally requires pulsatile administration of GnRH from the hypothalamus, whereas continuous administration of GnRH is known to prevent stimulation of the LH␤ and FSH␤ genes. The studies presented here as well as other studies involving cotransfection of GnRHR into GH 3 cells (21) did not require pulsatile administration of GnRH for FSH␤-Luc stimulation. This may be due in part to the fact that the GnRHR expression plasmid is driven by a CMV promoter, which continuously produces GnRHR and is not down-regulated by GnRH. Additionally, it has been shown in rat pituitary cell cultures that continuous GnRH treatment dramatically increases the level of follistatin, which would block the essential function of activin for FSH␤ expression (32) . The GnRH-responsive HeLa cells are not likely to produce follistatin under GnRH treatment and may not even produce activin. In some aspects, the HeLa cell system seems to be especially valuable in studying FSH␤ regulation, as it can be engineered to respond to only one hormone without interference of other pathways normally induced by that same hormone in gonadotrope cells.
In summary, we have used a GnRHR-expressing HeLa cell system to study the transcriptional regulation of the oFSH␤ gene and have shown that GnRH-mediated induction of oFSH␤ gene transcription involves two AP-1 enhancers and PKC activation. In addition, these studies demonstrate the usefulness of GnRHR-expressing HeLa cells to study the effects of GnRH on gonadotropin subunit gene expression, as GnRHR signaling in HeLa cells leads to normal mobilization of intracellular calcium, activation of PKC, activation/ induction of AP-1, and stimulation of ␣ and FSH␤ promoter activities. The roles of these AP-1 sites in GnRH regulation of oFSH␤ gene transcription in vivo are currently under investigation using transgenic mouse models.
